Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

ABT 43.07 +0.33 (0.77%)
price chart
Abbott Labs to Buy Private Medical Device Company Topera
Abbott Laboratories recently tweaked the terms of its agreement to sell a portion of its generic-drugs business to Mylan Inc. for $5.3 billion, signaling the deal will be completed despite new Treasury Department rules aimed at deterring tax-reducing ...
Abbott Labs to buy Menlo Park's Topera for $250M  Silicon Valley Business Journal
Abbott Labs to buy medical device company Topera  Chicago Business Journal
Related articles »  
Deutsche Bank Upgrades Abbott Laboratories
Moreover, "We believe Abbott can sustain mid-to-high single digit sales growth and 10%-12% EPS growth. Given this, its balance sheet and cash flows, we believe the stock should trade at a premium valuation and there is significant upside from< current ...
Abbott Laboratories Q3 Earnings: Global Sales Up 5.6%
Abbott Laboratories saw its third-quarter revenue rise 5.8 percent, to $5.1 billion, thanks to strong sales of branded pharmaceuticals and nutrition goods, along with a boost in its vision care products.
Abbott Sales Rise 5.8%; Mylan Terms Revised  Wall Street Journal
Abbott Laboratories (ABT) Earnings Report: Q3 2014 Conference Call Transcript  TheStreet.com
Related articles »  
Wednesday's Analyst Moves: Abbott Laboratories, Amgen, Inc., General ...
Wednesday's Analyst Moves: Abbott Laboratories, Amgen, Inc., General Dynamics Corporation, More (ABT, AMGN, GD, More). By Shauna O'Brien|October 29th, 2014.
Today's Unusual Social Activity Stock: Abbott Laboratories (ABT)
Abbott Laboratories manufactures and sells health care products worldwide. The stock currently has a dividend yield of 2.1%.
Related articles »  
Abbott Labs Pays $250 Million for Topera in Heart Health Move
Abbott Laboratories (ABT) entered the heart rhythm disorder market on Wednesday with the purchase of Topera Inc. as well as the option to buy Advanced Cardiac Therapeutics (ACT) .
Abbott Laboratories' EPS Up 12% On Emerging Market Strength
Abbott Laboratories (NYSE:ABT) is a large cap ($64 billion market cap) diversified health care provider. The company has paid increasing dividend payments for 42 consecutive years.
Abbott Laboratories shuttle bus overturns
No one was hurt Monday when an Abbott Laboratories shuttle bus overturned at routes 43 and 137 in North Chicago, authorities said.
Related articles »  
Stock Update: Abbott Laboratories (NYSE:ABT) - Abbott Expands Its Medical ...
Abbott Laboratories (NYSE:ABT) [PR Newswire] - ABBOTT PARK, Ill., Oct. 29, 2014 /PRNewswire/ - Abbott (ABT) today announced that it has entered into an agreement to purchase Topera, Inc., a private, venture-backed medical device company focused ...
January 2017 Options Now Available For Abbott Laboratories (ABT)
Investors in Abbott Laboratories (NYSE: ABT) saw new options begin trading today, for the January 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 830 days until expiration ...
Related articles »